Uveitis Market Insight, Epidemiology and Market Forecast to 2034: Assessment of Competitors, Market, Current Trends and Upcoming Treatments [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
The latest report on the Uveitis market provides valuable insights into the disease's prevalence, emerging treatment options, and market trends through to the year 2034. With an extensive analysis of the epidemiological patterns and market dynamics across the US, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan, industry stakeholders can anticipate significant growth driven by innovation and increased disease awareness. Advancements in Treatment and Diagnosis Advances in the understanding of the pathogenesis of uveitis are propelling the market forward. The report highlights the integration of "omics" technologies and ocular immunology, contributing to the development of novel clinical trials, drug delivery systems, and diagnostic imaging. The introduction of corticosteroids as first-line therapy, alongside immunomodulatory drugs, reflects the progression in treatment strategies, while surgical interventions are reserved for severe cases. Challenges and Op
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Novo Nordisk To Slash Prices On Buzzy Drugs Ozempic and Wegovy [Yahoo! Finance]Yahoo! Finance
- 25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says [FOX Business Network]FOX Business Network
- Here Comes Obesity Drug Competition: Amgen Shares Soar On "Very Encouraging" Clinical Trial Update [zero hedge]zero hedge
- How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand' for weight-loss drugs [Yahoo! Finance]Yahoo! Finance
- How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand' for weight-loss drugs [Fortune]Fortune
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- 4/16/24 - Form 4
- LLY's page on the SEC website